C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2011
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2438116C Amphoteric liposomes and the use thereof
10/11/2011	CA2437043C Ligand detection method
10/11/2011	CA2430314C Gene encoding acetolactate synthase
10/11/2011	CA2427665C Method for the production of a heterologous protein by a fungus
10/11/2011	CA2362098C Human polyclonal antibodies from genetically engineered animals
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/11/2011	CA2339421C Transgenic microbial polyhydroxyalkanoate producers
10/11/2011	CA2336743C Antigenic peptides derived from telomerase
10/11/2011	CA2315017C Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes
10/11/2011	CA2157932C Production of human papillomavirus capsid protein and virus-like particles
10/06/2011	WO2011123842A2 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
10/06/2011	WO2011123826A2 Prevention and treatment of cast nephropathy
10/06/2011	WO2011123749A1 Compositions and methods for adenylating oligonucleotides
10/06/2011	WO2011123708A2 Genetic engineering of non-human animals for the production of chimeric antibodies
10/06/2011	WO2011123683A2 Protease activated cytokines
10/06/2011	WO2011123570A2 Methods for g-csf production in a pseudomonas host cell
10/06/2011	WO2011123394A1 Modulation of matrix metalloproteinase 13 (mmp-13) expression
10/06/2011	WO2011123154A2 Metabolic evolution of escherchia coli strains that produce organic acids
10/06/2011	WO2011123139A1 High level expression of recombinant crm197
10/06/2011	WO2011123088A1 Compositions and methods for the production of recombinant virus vectors
10/06/2011	WO2011122950A1 Monomeric duplex aav vectors
10/06/2011	WO2011122889A2 Method for inhibiting the senescence of adult stem cells by inhibiting mirna expression
10/06/2011	WO2011122864A2 Method for determining genotoxicity using non-fluorescent proteins
10/06/2011	WO2011122859A2 Composition for predicting chance of brain tumor recurrence and survival prognosis, and kit containing same
10/06/2011	WO2011122857A2 Composition for predicting prognosis of breast cancer, and kit containing same
10/06/2011	WO2011122761A2 Gsdl2 protein having a life-extension function for plants and a stress resistance function for plants, gene thereof, and use thereof
10/06/2011	WO2011122740A1 Environmental stress-inducible 557 promoter isolated from rice and uses thereof
10/06/2011	WO2011122634A1 Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma
10/06/2011	WO2011122616A1 Method of manufacturing zeaxanthin by fermentation
10/06/2011	WO2011122611A1 Cancer vaccine
10/06/2011	WO2011122501A1 Method for distinguishing target base sequence
10/06/2011	WO2011122436A1 Microinjection device
10/06/2011	WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof
10/06/2011	WO2011122034A1 Method for detecting pneumonia causative bacteria using nucleic acid chromatography
10/06/2011	WO2011122022A1 Ect2 peptides and vaccines including the same
10/06/2011	WO2011122021A1 Marker for prediction of recurrence of hepatocellular carcinoma
10/06/2011	WO2011121881A1 Biopolymer analysis method, biopolymer analyzer, and biopolymer analysis chip
10/06/2011	WO2011121768A1 Novel cellulase gene
10/06/2011	WO2011121636A1 Method for producing induced pluripotent stem cells
10/06/2011	WO2011121257A1 Tools for the identification of lingo-1, lingo-2, lingo-3 and lingo-4, ligands, and uses thereof
10/06/2011	WO2011120952A1 Protein production in filamentous fungi
10/06/2011	WO2011120885A1 Hcv ns5a replicon shuttle vectors
10/06/2011	WO2011120549A1 Method of enhancing the seed yield and promoting the growth of plants
10/06/2011	WO2011120474A1 Method for inhibiting hiv replication in mammal and human cells
10/06/2011	WO2011120332A1 Double-stranded rna molecules with stability in mammalian body fluid, preparation and application thereof
10/06/2011	WO2011120165A1 Macrocyclic lactone resistance marker for dirofilaria immitis
10/06/2011	WO2011120156A1 Polyamine-containing polymers and methods of synthesis and use
10/06/2011	WO2011120135A1 Antibodies with enhanced or suppressed effector function
10/06/2011	WO2011120134A1 Antibodies with enhanced or suppressed effector function
10/06/2011	WO2011084255A3 Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
10/06/2011	WO2011081294A3 Recombinant adenovirus having anti-angiogenesis activity
10/06/2011	WO2011071632A3 Modified insm1-promoter for neuroendocrine tumor therapy and diagnostics
10/06/2011	WO2011071574A3 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
10/06/2011	WO2011066571A3 Assays for mutagenesis detection
10/06/2011	WO2011059508A3 Methods for pcr and hla typing using raw blood
10/06/2011	WO2011059285A3 Genotyping method
10/06/2011	WO2011056911A3 Compositions and methods for enhancing production of a biological product
10/06/2011	WO2011053864A3 Bacterial metastructure and methods of use
10/06/2011	WO2011053660A3 Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroendocrine tumors
10/06/2011	WO2011046382A3 Nrf2 inhibitors and use thereof
10/06/2011	WO2011041350A9 Xenotropic mulv-related virus (xmrv) compositions and methods of use
10/06/2011	WO2011034935A3 Transcription biomarkers of biological responses and methods
10/06/2011	WO2011029881A3 A method for binding a recombinant polypeptide to a carrier
10/06/2011	WO2011028929A3 Nitrate-responsive promoter
10/06/2011	WO2011019815A3 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
10/06/2011	WO2011011463A3 Manipulation of an alternative respiratory pathway in photo-autotrophs
10/06/2011	WO2010102363A8 Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites
10/06/2011	WO2010042281A9 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
10/06/2011	US20110247104 Homologous recombination-mediated transgene deletion in plant cells
10/06/2011	US20110247103 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
10/06/2011	US20110247102 Constitutive promoters from poplar and uses thereof
10/06/2011	US20110247101 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
10/06/2011	US20110247099 Genetic transformation of jatropha curcas
10/06/2011	US20110247098 Plants Having Enhanced Abiotic Stress Tolerance and/or Enhanced Yield-Related Traits and a Method for Making the Same
10/06/2011	US20110247097 Plants having modified growth characteristics and a method for making the same
10/06/2011	US20110247096 Plant Root-Specific Nematode Resistance
10/06/2011	US20110247095 Method of expression of foreign gene in plant induced by chemical substance
10/06/2011	US20110247094 Transgenic Plants with Enhanced Agronomic Traits
10/06/2011	US20110247092 Osteospermum and dimorphoteca plants having an altered flower phenotype
10/06/2011	US20110247091 Transgenic Cells and Chickens Expressing RIG-I
10/06/2011	US20110247090 Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression
10/06/2011	US20110247089 Organisms homozygous for targeted modification
10/06/2011	US20110247088 Tetracycline inducible transcription control sequence
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245772 Focal calcium channel modulation
10/06/2011	US20110245482 Non-invasive detection of fetal genetic traits
10/06/2011	US20110245472 Method for the mass production of immunoglobulin constant region
10/06/2011	US20110245470 Immunoglobulins
10/06/2011	US20110245464 Highly thermostable fluorescent proteins
10/06/2011	US20110245458 Peptide nucleic acid monomers and oligomers
10/06/2011	US20110245329 Double-stranded rna structures and constructs, and methods for generating and using the same
10/06/2011	US20110245328 HCV NS5A Replicon Shuttle Vectors
10/06/2011	US20110245325 Pharmaceutical composition for treatment of cancer and asthma
10/06/2011	US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
10/06/2011	US20110245320 Nuclease resistant double-stranded ribonucleic acid
10/06/2011	US20110245319 RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
10/06/2011	US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011	US20110245186 Recombinant e-selectin made in insect cells
10/06/2011	US20110245184 Treatment of surgical adhesions

1 ... 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 ... 4023